Sidal supplies more than 25 therapeutic types to hospitals worth over 25 billion dinars

Sidal Group has supplied more than 25 strategic therapeutic types to the Central Pharmacy of Hospitals, valued at over 25 billion Algerian dinars since the beginning of 2026, coinciding with the launch of projects to produce pharmaceutical raw materials in four states and develop innovative drugs and enhance cancer treatment manufacturing. Nargis Brichi, the marketing and sales director of the group, explained during her appearance on the 'Guest of the Morning' program on the First National Radio, that these efforts aim to secure the needs of the national health system and reduce the drug import bill, emphasizing that ensuring the availability of vital medicines and reducing dependence on foreign markets are strategic priorities for the group. Watch the full content...